Vancouver, British Columbia--(Newsfile Corp. - July 30, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy tests ...
BioMark is pioneering liquid biopsy solutions for challenging conditions and championing equity in diagnosis The diagnostic delay for rare diseases varies from months to decades, and some may never ...
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for early ...
Detailed price information for Biomark Diagnostics Inc (BMKDF) from The Globe and Mail including charting and trades.
Expansion of BioMark brings advanced equipment and doubles capacity, accelerating commercialization of lung cancer assay Vancouver, British Columbia--(Newsfile Corp. - August 5, 2025) - BioMark ...
BioMark Diagnostics Inc. research and ratings by Barron's. View BMKDF revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
As part of the transaction, Biomark Capital transferred their ownership of the HyperMed assets and made an equity-based investment in SafetySpect. The terms of the deal remain undisclosed. This ...
"Biomark Capital's acquisition of SafetySpect equity is a result of its confidence in SafetySpect's leadership, vision, and ability to scale advanced imaging solutions," said Douglas Lind, M.D., a ...
(MENAFN- Newsfile Corp) BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum BioMark Comprehensive Metabolomics Assay Selected as Top Canadian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results